Oklahoma Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center

• Category: Corporations - Public - Licenses
• State: Multi-State
• Control #: US-EG-9161
• Format: Word; Rich Text

Description

Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center at Forth Worth dated July 1, 1996. 2 pages The Oklahoma Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a legal document that outlines the rights and obligations of both parties in relation to intellectual property and commercialization efforts. The agreement serves as the foundation for a collaborative partnership between Gentling, Inc., a biotechnology company specializing in genetic research and development, and The University of North Texas Health Science Center, a renowned educational and research institution. Keywords: Oklahoma, Collateral License Agreement, Gentling, Inc., The University of North Texas Health Science Center, intellectual property, commercialization, partnership, biotechnology, genetic research, research institution. ***Types of Oklahoma Collateral License Agreement*** 1. Research Collaboration Agreement: This type of Oklahoma Collateral License Agreement focuses on collaborative research efforts between Gentling, Inc. and The University of North Texas Health Science Center. It outlines the terms and conditions for sharing research findings, intellectual property rights, and commercialization prospects arising from the collaboration. 2. Intellectual Property License Agreement: This variant of the Oklahoma Collateral License Agreement specifically addresses the transfer of intellectual property rights from The University of North Texas Health Science Center to Gentling, Inc. It defines the scope of the license, potential exclusivity, and any financial considerations associated with the licensed intellectual property. 3. Technology Transfer Agreement: This type of Oklahoma Collateral License Agreement focuses on the transfer of technologies developed or owned by The University of North Texas Health Science Center to Gentling, Inc. It encompasses the rights and obligations of both parties regarding technology transfer, further development, and commercialization. 4. Commercialization Agreement: This variant of the Oklahoma Collateral License Agreement primarily emphasizes the commercialization of intellectual property or technologies developed jointly or independently by Gentling, Inc. and The University of North Texas Health Science Center. It discusses revenue-sharing agreements, marketing strategies, and other aspects related to bringing products or services to market. These types of agreements may be signed individually or as a combination, depending on the specific goals and objectives of the partnership between Gentling, Inc. and The University of North Texas Health Science Center. Each agreement tailors the terms and conditions to address the specific nature of the collaborative efforts and commercialization potential between the two entities.

The Oklahoma Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a legal document that outlines the rights and obligations of both parties in relation to intellectual property and commercialization efforts. The agreement serves as the foundation for a collaborative partnership between Gentling, Inc., a biotechnology company specializing in genetic research and development, and The University of North Texas Health Science Center, a renowned educational and research institution. Keywords: Oklahoma, Collateral License Agreement, Gentling, Inc., The University of North Texas Health Science Center, intellectual property, commercialization, partnership, biotechnology, genetic research, research institution. ***Types of Oklahoma Collateral License Agreement*** 1. Research Collaboration Agreement: This type of Oklahoma Collateral License Agreement focuses on collaborative research efforts between Gentling, Inc. and The University of North Texas Health Science Center. It outlines the terms and conditions for sharing research findings, intellectual property rights, and commercialization prospects arising from the collaboration. 2. Intellectual Property License Agreement: This variant of the Oklahoma Collateral License Agreement specifically addresses the transfer of intellectual property rights from The University of North Texas Health Science Center to Gentling, Inc. It defines the scope of the license, potential exclusivity, and any financial considerations associated with the licensed intellectual property. 3. Technology Transfer Agreement: This type of Oklahoma Collateral License Agreement focuses on the transfer of technologies developed or owned by The University of North Texas Health Science Center to Gentling, Inc. It encompasses the rights and obligations of both parties regarding technology transfer, further development, and commercialization. 4. Commercialization Agreement: This variant of the Oklahoma Collateral License Agreement primarily emphasizes the commercialization of intellectual property or technologies developed jointly or independently by Gentling, Inc. and The University of North Texas Health Science Center. It discusses revenue-sharing agreements, marketing strategies, and other aspects related to bringing products or services to market. These types of agreements may be signed individually or as a combination, depending on the specific goals and objectives of the partnership between Gentling, Inc. and The University of North Texas Health Science Center. Each agreement tailors the terms and conditions to address the specific nature of the collaborative efforts and commercialization potential between the two entities.